Ken Frazier, Merck CEO (Bess Adler/Bloomberg via Getty Images)

Ex-Mer­ck chief Ken Fra­zier takes a lead­ing role in a $600M 'Health As­sur­ance' ven­ture fund

Ken Fra­zier has opened up a new chap­ter in his sto­ried ca­reer.

The ex-Mer­ck CEO is join­ing a high-mind­ed ven­ture group with plans to carve a unique role for it­self at the well-trav­eled junc­ture of tech and life sci­ences. And the new job comes through an old col­lege bud­dy.

Of­fi­cial­ly, Fra­zier now be­comes chair­man of Gen­er­al Cat­a­lyst’s health as­sur­ance ini­tia­tive. Their $600 mil­lion fund was un­veiled back in ear­ly April, plan­ning to in­vest in com­pa­nies that could push the “evo­lu­tion from a ‘sick care’ sys­tem to a re­silient, proac­tive Health As­sur­ance sys­tem de­signed to help peo­ple stay well, bend the cost curve, and make qual­i­ty care more af­ford­able and more ac­ces­si­ble to all.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.